HOUSTON, December 09, 2025--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announced that dosing of ALS patients in the Company’s ALSTARS Trial of COYA 302 has commenced. Dr.… Read More..

Proof Of Concept Phase Complete – Production Shipments To Start December 2025 HAUPPAUGE, N.Y., Dec. 01, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (NASDAQ: AMPG), a leading designer, developer, and manufacturer of state-of-the-art signal processing components, low-noise amplifiers (LNAs), and advanced 5G/6G ORAN systems, today announced formal release of its… Read More..

TAMPA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking, today announced that its wholly owned subsidiary, Wilson-Davis & Co. (“WDCO”), has filed its October 2025 FOCUS Report with FINRA, reflecting… Read More..